- Home
- TAK vs MFC Comparison
TAK vs MFC Comparison
Compare TAK & MFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAK
- MFC
- Stock Information
- Founded
- TAK 1781
- MFC 1887
- Country
- TAK Japan
- MFC Canada
- Employees
- TAK N/A
- MFC N/A
- Industry
- TAK Biotechnology: Pharmaceutical Preparations
- MFC Life Insurance
- Sector
- TAK Health Care
- MFC Finance
- Exchange
- TAK Nasdaq
- MFC Nasdaq
- Market Cap
- TAK 45.8B
- MFC 49.3B
- IPO Year
- TAK N/A
- MFC 1999
- Fundamental
- Price
- TAK $14.68
- MFC $30.47
- Analyst Decision
- TAK
- MFC Buy
- Analyst Count
- TAK 0
- MFC 1
- Target Price
- TAK N/A
- MFC $51.00
- AVG Volume (30 Days)
- TAK 2.3M
- MFC 2.3M
- Earning Date
- TAK 07-30-2025
- MFC 08-06-2025
- Dividend Yield
- TAK 3.70%
- MFC 3.93%
- EPS Growth
- TAK N/A
- MFC 14.95
- EPS
- TAK 0.45
- MFC 1.85
- Revenue
- TAK $30,595,075,281.00
- MFC $20,887,744,800.00
- Revenue This Year
- TAK $1.01
- MFC $35.15
- Revenue Next Year
- TAK $1.04
- MFC $5.64
- P/E Ratio
- TAK $65.09
- MFC $15.90
- Revenue Growth
- TAK 7.45
- MFC 9.27
- 52 Week Low
- TAK $12.80
- MFC $23.30
- 52 Week High
- TAK $15.53
- MFC $33.07
- Technical
- Relative Strength Index (RSI)
- TAK 41.31
- MFC 40.45
- Support Level
- TAK $14.93
- MFC $30.44
- Resistance Level
- TAK $15.14
- MFC $30.90
- Average True Range (ATR)
- TAK 0.15
- MFC 0.51
- MACD
- TAK -0.06
- MFC -0.14
- Stochastic Oscillator
- TAK 11.86
- MFC 11.46
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
About MFC Manulife Financial Corporation
Manulife Financial provides life insurance, annuities, and asset management products to individuals and group customers in Canada, the United States, and Asia. Its investment management business contributes approximately 20% of its earnings and has around CAD 1.05 trillion in assets under management and administration as of the end of 2023. The US business, which primarily operates under the John Hancock brand, contributes about 27% of earnings and is mainly focused on providing insurance products for estate, business, and income protection. The Asia segment provides insurance products and insurance-based wealth accumulation products in over 11 countries and contributes around 30% of earnings. The Canadian business segment contributes approximately 23% of earnings.